Medical device group Mainstay plans €100m flotationIrish back pain group hopes to raise €20m to fund clinical trials and other costs of bringing device to marketWed Apr 09 2014 - 21:54
Biopharma group Alexion to hire 200 at new Dublin plantRare disease specialist’s €75m investment is third base in Ireland and comes just nine months after initial entry to marketThu Apr 03 2014 - 10:15
GSK recalls anti-depressant after contamination in CorkFDA issues warning after firms’s failure to address concerns since October inspectionTue Apr 01 2014 - 22:10
Back pain group plans stock market floatMainstay Medical looking to list in Paris and Dublin as it trials first productThu Mar 27 2014 - 19:40
Dublin tech company to work with US biopharma groupGenable Technologies will licence certain intellectual property from Spark under dealWed Mar 26 2014 - 11:45
Deadline looms again for Vodafone shareholdersInvestors seeking forms to sell Verizon shares in ‘commission free’ offer must contact registrar by tomorrowTue Mar 25 2014 - 20:20
The Vodafone queries continueTax obligations, losses on shares and a 'casual approach to paperwork'.Tue Mar 25 2014 - 01:05
Q&A Dominic Coyle: Will Revenue charge gift tax if I pay for daughter’s wedding?Tue Mar 11 2014 - 01:05
Mainstay starts clinical trials on back pain therapyImplanted Reactiv8 unit designed to stabilise spinal muscles with electrical impulsesMon Mar 10 2014 - 01:00
Revenue in line for windfall from Vodafone shareholdersComputershare focus of anger over tax liabilitiesThu Mar 06 2014 - 01:00
How to complain over Computershare handling of Vodafone payoutQ&A Dominic Coyle: Shareholders should act now and ensure they follow the complaints procedure closelyTue Mar 04 2014 - 01:08
Vodafone investor gets letter of rejection overturnedCase raises hope for Irish Vodafone shareholders who had choices rejected by Computershare on grounds they missed deadlineMon Mar 03 2014 - 01:00
Perrigo offloads Elan Alzheimer drug candidateCompany does deal with partner Transition Therapeutics as it separately spends $51m on over-the-counter products in AustraliaSat Mar 01 2014 - 01:00
Vodafone faces backlash over shares deadlineInvestors frustrated in efforts to claim portion of $80bn windfall from telcoFri Feb 28 2014 - 22:19
Amarin takes legal action against FDA over patent protection for VascepaCompany continues to fight regulator as it reports $166m loss in first year of commercial operation for fish oil drugThu Feb 27 2014 - 22:23
Alkermes beats forecasts as it delivers record revenues for 2013Biopharma group bullish on prospects for pipeline and existing portfolio this yearThu Feb 27 2014 - 21:23
Noonan accused of ‘abdicating responsibility’ on pensionsIAPF says decision to continue levy will impoverish pensionersThu Feb 27 2014 - 21:00
Clinical trials group Venn buys synthetic skin technologyAcquisition of LabSkin from Evocutis will address EU ban on animal testing for skincare and cosmetic productsWed Feb 26 2014 - 22:14
Jazz shares fall as market digests ongoing row with FDAOutlook for 2014 bullish after strong results for 2013, depsite fourth quarter undershooting analyst projectionsWed Feb 26 2014 - 22:05
Oneview lands hospital software contractIrish healthcare information specialist will bring together hospital IT systems to enhance patient care at new $1.5bn California unitWed Feb 26 2014 - 22:05
Biopharma specialist Alexion applies for Dublin HQApplication for proposed headquarters in Blanchardstown, west DublinTue Feb 25 2014 - 01:00
Top pharma exec urges Ireland to focus on gap in industry technology developmentAcademic teams with input from strategic suppliers can deliver valuable solutionsFri Feb 21 2014 - 01:00
‘Sometimes we forget that our products are taken by millions every day’GSK may be a global business but its Irish plants continue to figure highly, says its head of global manufacturing and supplyFri Feb 21 2014 - 01:00
Vodafone shareholders get details of payout in Verizon dealBritish telecoms group also announces stock consolidation which will see shareholders hold six new shares on Monday instead of 11 existing onesWed Feb 19 2014 - 22:56
Vodafone shareholders to get forms after U-turnShare registrar had told callers deadline had passed but are now mailing formsFri Feb 14 2014 - 21:23
Deadline day for Vodafone shareholdersComputershare ‘will not be sending any new forms out after today’Fri Feb 14 2014 - 01:01
Alimentary Health launches IBS therapyProbiotic from Cork firm available over the counterFri Feb 14 2014 - 01:01
Alexion names Julie O’Neill as head of Irish operationBiopharma industry veteran to lead US company’s establishment of global supply-chain operationMon Feb 10 2014 - 01:00
Takeover of Elan the perfect fit in Perrigo’s prescription for growthFor Perrigo chief Joe Papa, the acquisition of Ireland’s largest indigenous drug company was a ‘perfect gateway’ in its plans to expand internationallyFri Feb 07 2014 - 01:00
Vodafone payout is no ‘windfall’, just a payment to ease the sufferingQ&A Dominic CoyleTue Feb 04 2014 - 01:30
Making sense of Vodafone share optionsQ&A: Dominic Coyle continues to tackle the Vodafone issueTue Jan 28 2014 - 17:38
Vodafone share deal windfall to escape taxIrish investors to gain €27.5m from sale of US businessTue Jan 21 2014 - 01:00
Irish pension funds grew by 16.6% in 2013Rise followed solid returns in the final quarterWed Jan 08 2014 - 01:00
Pharma industry is edging towards transparencyBusiness opinion: the sector’s mixed record gives little cause for reassuranceMon Jan 06 2014 - 01:00
Q&A Dominic CoyleWill approved retirement fund make me ineligible for medical card?Tue Dec 17 2013 - 01:00
Far from doomsday for pharma sectorJob cuts at Pfizer, Baxter and MSD look like a worrying trend but it is too early to call it a crisisThu Dec 05 2013 - 11:13
Pfizer cuts 150 jobs at Newbridge with closure of packaging plantPharma giant blames falling sales and competition but holds out hope for the futureThu Dec 05 2013 - 09:29
Q&A Dominic Coyle: Reckonable income limits for pensionsUnearned income not relevant for pension contributionsTue Dec 03 2013 - 01:00
